
Conference Coverage
Latest Content

AV Gives CLL Patients a Fixed-Duration Oral Path: Adam Kittai, MD

FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA

Combining BTK and BCL2 Inhibitors in Mantle Cell Lymphoma: Eyre Weighs in on Where the Field Goes Next

Treatment for Thyroid Eye Disease Approved by FDA

When Standard Chemo Isn’t the Answer in ALL: Emily K. Curran, MD

Shorts










Podcasts
Center on Health Equity & Access
All News

Summary of Nonconsensus Discussions: Bridging the Gaps in Health Equity & Access in Multiple Myeloma | May 2, 2026, Tampa, Florida

Insurance and socioeconomic factors delay optimal anti-VEGF care for diabetic macular edema, worsening vision disparities.

National HIV Testing Day highlights how state policies, pharmacists, and long-acting therapies are reshaping access to HIV testing, PrEP, and PEP.

Obesity coding gaps limit care; MCL rising in women; racial pain disparities in oncology; AML access expands; SDOH rivals genetics.

New research reveals complex treatment costs from MM strain patients and caregivers during active therapy, while pain goes undertreated at end of life.

A single-center study found low rates of MRA and SGLT2 inhibitor prescribing among low-income, largely uninsured patients with heart failure.

Lower rates of successful discharge were reported in home health care patients whose care was interrupted by flooding related to hurricanes.

Participants highlight critical gaps in the diagnosis, treatment, and coordination of care for patients with heart failure.

Deloitte's Pete Lyons explains the confidence gap, diverging biopharmaceutical and medical technology risks, and what separates real AI value from activity.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.






















